Why Does an OCD Psilocybin Protocol Compare Neutral and Provoked States?
A brain measurement can depend on the participant’s state during recording. Ledwos and colleagues’ protocol for treatment-resistant obsessive–compulsive disorder plans to examine that issue by recording during neutral and symptom-provoked conditions.
Two kinds of comparison
The open-label pilot plans psilocybin-assisted psychotherapy for ten adults. Neurophysiology visits before and after the intervention include resting EEG, task-related EEG and TMS-EEG. Within those visits, the investigators plan to alternate neutral and symptom-provocation phases.
The before-and-after comparison concerns change across the intervention period. The neutral-versus-provoked comparison concerns symptom state during a visit. Keeping both dimensions visible helps prevent a state-dependent measurement difference from being described simply as an overall treatment effect.
Check that the intended state occurred
The protocol includes participant ratings of symptom severity during the phases. These ratings provide information about whether the provocation produced the intended level of symptoms. They complement the electrophysiological measurements rather than being interchangeable with them.
The different recording approaches also address different aspects of brain activity. Resting recordings, an auditory task and responses to stimulation should not be collapsed into one undifferentiated measure of improvement.
A plan does not supply an outcome
The publication describes intended procedures and exploratory relationships between brain measures and symptom changes. It does not report that the planned participants improved or that any neural marker tracked improvement.
Its small, open-label design has no concurrent placebo comparison isolating the intervention’s effects. The protocol can help readers understand what a future result would mean, including which state and assessment time produced it. It cannot itself establish efficacy or a causal mechanism.
Source: Ledwos N et al. Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study. BJPsych Open, 2026 journal issue. DOI: 10.1192/bjo.2025.10895.



